Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ongoing Investigation: Boston Scientific Corporation (BSX) May Have Misled Shareholders - Levi & Korsinsky Investigates

New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.58 (-1.51%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such...

BSX : 74.58 (-1.51%)
3 S&P 500 Stocks Worth Investigating

3 S&P 500 Stocks Worth Investigating

TT : 467.12 (+0.74%)
BSX : 74.58 (-1.51%)
ZTS : 128.78 (+1.18%)
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

MARLBOROUGH, Mass. , Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46 th Annual Health Care Conference on Tuesday, March 3, 2026. Mike...

BSX : 74.58 (-1.51%)
The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call

The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call

BSX : 74.58 (-1.51%)
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)

New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific...

BSX : 74.58 (-1.51%)
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Boston Scientific Corporation (“Boston Scientific”...

BSX : 74.58 (-1.51%)
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.58 (-1.51%)
3 Safe-and-Steady Stocks to Consider Right Now

3 Safe-and-Steady Stocks to Consider Right Now

BR : 177.02 (+0.46%)
INTU : 380.55 (-0.26%)
BSX : 74.58 (-1.51%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX ) investors concerning the...

BSX : 74.58 (-1.51%)

Barchart Exclusives

Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip?
Grail stock crashed on Friday after its NHS-Galleri clinical trial failed to meet primary endpoint. Here’s why investors are cautioned against treating GRAL shares as a bargain. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar